Guy Fournet

1.1k total citations
47 papers, 844 citations indexed

About

Guy Fournet is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Guy Fournet has authored 47 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 22 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Guy Fournet's work include Catalytic Cross-Coupling Reactions (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cyclopropane Reaction Mechanisms (5 papers). Guy Fournet is often cited by papers focused on Catalytic Cross-Coupling Reactions (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cyclopropane Reaction Mechanisms (5 papers). Guy Fournet collaborates with scholars based in France, Spain and United States. Guy Fournet's co-authors include J. GORÉ, Geneviève Balme, Benoı̂t Joseph, G Quash, Didier Le Bars, İsmail Çeylan, Uwe Reichert, Charles Dumontet, Régis Costello and Mileidys Pérez‐Alea and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical Journal.

In The Last Decade

Guy Fournet

46 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Fournet France 20 411 279 150 126 52 47 844
Chu‐Biao Xue United States 22 320 0.8× 577 2.1× 197 1.3× 108 0.9× 13 0.3× 52 1.0k
Darren McKerrecher United Kingdom 16 466 1.1× 508 1.8× 168 1.1× 75 0.6× 129 2.5× 28 1.2k
Michael N. Greco United States 18 489 1.2× 432 1.5× 157 1.0× 61 0.5× 135 2.6× 32 967
Geeta Patel United Kingdom 18 224 0.5× 288 1.0× 166 1.1× 54 0.4× 31 0.6× 45 732
Eliud Hernandez O'Farril Puerto Rico 15 246 0.6× 412 1.5× 124 0.8× 62 0.5× 30 0.6× 31 755
Moshe Weitzberg United States 15 266 0.6× 242 0.9× 62 0.4× 125 1.0× 18 0.3× 28 638
Kristi Leonard United States 15 338 0.8× 253 0.9× 183 1.2× 31 0.2× 40 0.8× 24 699
Jeffrey O. Saunders United States 9 192 0.5× 363 1.3× 212 1.4× 117 0.9× 18 0.3× 12 877
Michel Weïwer United States 20 608 1.5× 811 2.9× 187 1.2× 124 1.0× 141 2.7× 31 1.3k
Wanjun Zheng United States 14 358 0.9× 281 1.0× 194 1.3× 65 0.5× 47 0.9× 19 907

Countries citing papers authored by Guy Fournet

Since Specialization
Citations

This map shows the geographic impact of Guy Fournet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Fournet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Fournet more than expected).

Fields of papers citing papers by Guy Fournet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Fournet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Fournet. The network helps show where Guy Fournet may publish in the future.

Co-authorship network of co-authors of Guy Fournet

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Fournet. A scholar is included among the top collaborators of Guy Fournet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Fournet. Guy Fournet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rios, R. R., et al.. (2025). 60P ALDH1 isoform landscape in breast cancer: Advancing precision therapies with a potent ALDH1A3-selective inhibitor. ESMO Open. 10. 104220–104220. 1 indexed citations
2.
Janji, Bassam, Akinchan Kumar, Xavier Parés, et al.. (2025). Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors. Cell chemical biology. 32(10). 1260–1278.e12.
3.
Leroy, Catherine, Guy Fournet, Benoı̂t Joseph, et al.. (2023). Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System. Biomedicines. 11(10). 2801–2801. 9 indexed citations
4.
Rios, R. R., Geoffroy Venton, Sara Sánchez‐Redondo, et al.. (2020). Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer. Oncogene. 39(13). 2756–2771. 41 indexed citations
5.
Pérez‐Alea, Mileidys, Sara Sánchez‐Redondo, Berta Ferrer-Rosell, et al.. (2017). ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment. Oncogene. 36(41). 5695–5708. 49 indexed citations
6.
Venton, Geoffroy, Mileidys Pérez‐Alea, Guy Fournet, et al.. (2016). Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors. Blood Cancer Journal. 6(9). e469–e469. 54 indexed citations
7.
Lin, Xiaochen, Karin Sadoul, Guy Fournet, et al.. (2015). Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin Antagonists. PLoS ONE. 10(10). e0141205–e0141205. 4 indexed citations
8.
Fournet, Guy, et al.. (2014). Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors.. HAL (Le Centre pour la Communication Scientifique Directe). 11 indexed citations
9.
Fournet, Guy, et al.. (2014). New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. European Journal of Medicinal Chemistry. 75. 159–168. 15 indexed citations
10.
Fournet, Guy, Guy Martin, & G Quash. (2013). α,β-Acetylenic Amino Thiolester Inhibitors of Aldehyde Dehydrogenases 1&3: Suppressors of Apoptogenic Aldehyde Oxidation and Activators of Apoptosis. Current Medicinal Chemistry. 20(4). 527–533. 22 indexed citations
11.
12.
13.
Verdurand, Mathieu, Benoı̂t Joseph, Laëtitia Lemoine, et al.. (2007). Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand. Nuclear Medicine and Biology. 34(8). 995–1002. 18 indexed citations
14.
Joucla, Lionel, et al.. (2005). Preparation of Azepinoindole Derivatives via Oxidative Palladium Couplings. Letters in Organic Chemistry. 2(8). 707–711. 4 indexed citations
15.
Thomas, Vincent, et al.. (2004). Definition of the fine specificity of the monoclonal antibody 81D4: its reactivity with lysine and polyamine isopeptide cross-links. Journal of Immunological Methods. 292(1-2). 83–95. 8 indexed citations
16.
Quash, G, Guy Fournet, & Uwe Reichert. (2003). Anaplerotic reactions in tumour proliferation and apoptosis. Biochemical Pharmacology. 66(3). 365–370. 11 indexed citations
17.
Zimmer, Luc, Guy Fournet, Benoı̂t Joseph, Gérald Guillaumet, & Didier Le Bars. (2003). Carbon-11 labelling of 8{{3-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]-2-hydroxypropyl}oxy}thiochroman, a presynaptic 5-HT1A receptor agonist, and its in vivo evaluation in anaesthetised rat and in awake cat. Nuclear Medicine and Biology. 30(5). 541–546. 29 indexed citations
18.
Canuto, Rosa Angela, Giuliana Muzio, Marina Maggiora, et al.. (2001). The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and death. Chemico-Biological Interactions. 130-132(1-3). 209–218. 27 indexed citations
19.
20.
Fournet, Guy, et al.. (1988). Carbopalladation des alkylidenecyclopropanes-II capture intramoleculaire de l'organopalladique intermediaire. Tetrahedron. 44(18). 5821–5832. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chu‐Biao Xue Breakdown of academic impact, for papers by Darren McKerrecher Breakdown of academic impact, for papers by Michael N. Greco Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Eliud Hernandez O'Farril Breakdown of academic impact, for papers by Moshe Weitzberg Breakdown of academic impact, for papers by Kristi Leonard Breakdown of academic impact, for papers by Jeffrey O. Saunders Breakdown of academic impact, for papers by Michel Weïwer Breakdown of academic impact, for papers by Wanjun Zheng
Rankless by CCL
2026